PAVmed (PAVM) Insider Trading & Ownership $0.72 -0.04 (-5.26%) (As of 12/16/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends PAVmed (NASDAQ:PAVM) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage14.70%Number OfInsiders Buying(Last 3 Years)1Amount OfInsider Buying(Last 3 Years)$104,770.35Number OfInsiders Selling(Last 3 Years)0 Get PAVM Insider Trade Alerts Want to know when executives and insiders are buying or selling PAVmed stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address PAVM Insider Buying and Selling by Quarter Ad Crypto 101 MediaDeFi Coin on Verge of Breakout!The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Claim your FREE book now before it's too late! PAVmed Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/7/2022Michael J GlennonDirectorBuy6,666$9.30$61,993.80 12/5/2022Michael J GlennonDirectorBuy4,133$10.35$42,776.55 (Data available from 1/1/2013 forward) PAVM Insider Trading Activity - Frequently Asked Questions Who is on PAVmed's Insider Roster? The list of insiders at PAVmed includes Michael J Glennon. Learn more on insiders at PAVM. What percentage of PAVmed stock is owned by insiders? 14.70% of PAVmed stock is owned by insiders. Learn more on PAVM's insider holdings. PAVmed Key ExecutivesDr. Lishan Aklog M.D. (Age 58)Chairman & CEO Compensation: $953.2kMr. Dennis M. McGrath CPA (Age 67)President & CFO Compensation: $673.5kMr. Shaun M. O'Neill M.B.A. (Age 41)Executive VP & COO Compensation: $498kMr. Michael Adam Gordon (Age 49)Executive VP, General Counsel & Secretary Compensation: $710.5kDr. Brian J. deGuzman M.D. (Age 59)Executive VP, Chief Technology & Compliance Officer Compensation: $427.6kDr. Suman M. Verma M.D.Ph.D., Senior VP of Molecular Genetics & Chief Scientific OfficerMichael ParksVice President of Investor RelationsDr. Deepika A. Lakhani Ph.D.Senior VP, Chief Regulatory & Quality OfficerDr. Victoria T. Lee M.D.Senior VP & Chief Medical Officer More Insider Trading Tools from MarketBeat Related Companies Beyond Air Insider Buying Neuronetics Insider Buying Precision Optics Insider Buying IRIDEX Insider Buying Co-Diagnostics Insider Buying NEXGEL Insider Buying DarioHealth Insider Buying Vivos Therapeutics Insider Buying BioSig Technologies Insider Buying Nephros Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-ReportServiceNow: Will the High-Flyer Finally Split in 2024? This page (NASDAQ:PAVM) was last updated on 12/16/2024 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredWall Street Icon: “If you wait on this, it will already be too late”...Investing legend Louis Navellier warned us about the stock market crash of 1987... the 2000 dot-com crash… Enr...InvestorPlace | Sponsored"This looks and feels like 2000," says investing legendOur senior analyst Dan Ferris says a new surprise crisis could begin at any moment... and this time, he says i...Stansberry Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PAVmed Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PAVmed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
